News

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...
In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.
Metastasis-directed SABR has demonstrated benefit in oligometastatic castration-sensitive prostate cancer, but disease progression often occurs in bone. To assess whether adding Ra223 to SABR ...
This study presents a valuable meta-analysis of two independent genome-wide association studies (GWASs) elucidating the role of plasma proteins as biomarkers for improving early detection of prostate ...
A study has revealed that regular exercise can improve erectile dysfunction after treatment for prostate cancer, highlighting the importance of physical activity in sexual rehabilitation ...
For more than 15 years, Columbus CyberKnife has provided cutting-edge, compassionate care to men facing prostate cancer—treating over 2,000 patients with a non-invasive option that minimizes ...
WASHINGTON (AP) — A small nodule was found in the prostate of former President Joe Biden during a routine physical exam, a spokesperson said Tuesday. A short statement said the finding ...
ALBUQUERQUE, N.M. – According to national nonprofit Zero Prostate Cancer, 1 in 8 men will be diagnosed with prostate cancer in their lifetime. There were more than 299,000 newly diagnosed cases ...
Another way doctors may describe your cancer is as localised, locally advanced and metastatic prostate cancer. The type of prostate cancer tells you which type of cell the cancer started in. The most ...
A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co. (MSD) has just been launched in the US and Canada: ‘Never Miss ...